Relx PLC is a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The company shows strong revenue and profit growth, hedge funds are increasing their positions, and analysts maintain positive ratings despite AI concerns. The stock's technical indicators and options data suggest a neutral to slightly bullish sentiment, making it a solid entry point for long-term investment.
The MACD is positive at 0.282, indicating bullish momentum, though it is contracting. The RSI at 60.865 is neutral, showing no overbought or oversold conditions. Moving averages are converging, suggesting a potential trend reversal. Key support and resistance levels are at S1: 33.611 and R1: 37.325, with the pre-market price of 35.96 near the pivot level of 35.468.

Strong revenue and profit growth reported across all business areas.
Hedge funds are increasing their positions significantly, with a 147.40% increase in buying over the last quarter.
Analysts are upgrading the stock, with Citi upgrading to Buy and BofA raising the price target.
Partnership with Cytora to enhance insurance risk management, showcasing innovation and growth potential.
Pre-market price shows a slight decline of -0.47%, which could indicate short-term selling pressure.
Concerns around AI impact, though analysts believe these are overdone.
Relx reported strong revenue and profit growth at the start of 2026, with adjusted operating profit expected to exceed revenue growth for the year. Specific financial data was not provided, but the outlook remains positive.
Citi upgraded Relx to Buy from Neutral, citing valuation and downplaying AI concerns. BofA raised the price target to $47.20, emphasizing resilience in Q4 earnings. Morgan Stanley maintains an Overweight rating despite lowering the price target to 3,610 GBp.